Intended for use in the quality control of coagulation assays in the borderline
Intended for use in the quality control of coagulation assays in the borderline pathological range.
A pool of citrated human plasma collected from a minimum of 20 donors that has b
A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the highly abnormal range.
A pool of citrated human plasma collected from a minimum of 20 donors that has b
A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed, and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the mid-level abnormal range.
Assayed control plasma prepared from de-fibrinated human plasma intended for use
Assayed control plasma prepared from de-fibrinated human plasma intended for use in the quality control of quantitative fibrinogen assays in the low abnormal range.
Intended for use in the quality control of coagulation assays in the borderline
Intended for use in the quality control of coagulation assays in the borderline pathological range.
Assayed control plasma prepared from de-fibrinated human plasma intended for use
Assayed control plasma prepared from de-fibrinated human plasma intended for use in the quality control of quantitative fibrinogen assays in the low abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
Intended for the use in the quality control of quantitative coagulation assays,
Intended for the use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
Intended for the use in quality control of quantitative coagulation assays, incl
Intended for the use in quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
A pool of normal citrated human plasma collected from a minimum of 20 donors, bu
A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity.
A pool of citrated normal human plasma collected from a minimum of 20 donors, an
A pool of citrated normal human plasma collected from a minimum of 20 donors, and diluted to defined concentrations. Plasma is buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity.
A pool of normal citrated human plasma collected from a minimum of 20 donors, bu
A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT, APTT and Fibinogen) in the normal range.
The specific use of this ASR (Analyte Specific Reagent) will depend upon the end
The specific use of this ASR (Analyte Specific Reagent) will depend upon the end user's application.
MVU
Reagents, Specific, Analyte
1
Sheep anti-human Factor XIII Analyte Specific Reagent
The specific use of this ASR (Analyte Specific Reagent) will depend upon the end
The specific use of this ASR (Analyte Specific Reagent) will depend upon the end-user's application.
MVU
Reagents, Specific, Analyte
1
Sheep anti-human Factor XIII Analyte Specific Reagent
Validate Heparin is intended for the quantitative determination of Calibration V
Validate Heparin is intended for the quantitative determination of Calibration Verification/Linearity of the heparin anti-Xa activity on automated instruments
Validate Heparin is intended for the quantitative determination of Calibration V
Validate Heparin is intended for the quantitative determination of Calibration Verification/Linearity of the heparin anti-Xa activityon automated instruments
Validate Heparin is intended for the quantitative determination of Calibration V
Validate Heparin is intended for the quantitative determination of Calibration Verification/Linearity of the heparin anti-Xa activityon automated instruments
Validate D-Dimer is intended for the quantitative determination of Calibration V
Validate D-Dimer is intended for the quantitative determination of Calibration Verification/Linearity of drug analytes on automated instruments.
Validate D-Dimer is intended for the quantitative determination of Calibration V
Validate D-Dimer is intended for the quantitative determination of Calibration Verification/Linearity of drug analytes on automated instruments.
Validate D-Dimer is intended for the quantitative determination of Calibration V
Validate D-Dimer is intended for the quantitative determination of Calibration Verification/Linearity of drug analytes on automated instruments.
Lyphochek Coagulation Control Level Trilevel MiniPak (A human plasma coagulatio
Lyphochek Coagulation Control Level Trilevel MiniPak (A human plasma coagulation control.)
Prepared from human source plasma and recommended as a negative control in assay
Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant.
Prepared from human source plasma and recommended as a negative control in assay
Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant.
The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction
The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older.